Literature DB >> 32242228

The path forward for radiation therapy in the management of low-grade gliomas.

Shervin Tabrizi1,2, Helen A Shih1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32242228      PMCID： PMC7283024          DOI： 10.1093/neuonc/noaa085

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  8 in total

1.  The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity.

Authors:  Christina A Meyers; Jeffrey S Wefel
Journal:  J Clin Oncol       Date:  2003-08-11       Impact factor: 44.544

2.  Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Authors:  Jan C Buckner; Edward G Shaw; Stephanie L Pugh; Arnab Chakravarti; Mark R Gilbert; Geoffrey R Barger; Stephen Coons; Peter Ricci; Dennis Bullard; Paul D Brown; Keith Stelzer; David Brachman; John H Suh; Christopher J Schultz; Jean-Paul Bahary; Barbara J Fisher; Harold Kim; Albert D Murtha; Erica H Bell; Minhee Won; Minesh P Mehta; Walter J Curran
Journal:  N Engl J Med       Date:  2016-04-07       Impact factor: 91.245

3.  Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma.

Authors:  William G Breen; S Keith Anderson; Xiomara W Carrero; Paul D Brown; Karla V Ballman; Brian P O'Neill; Walter J Curran; Ross A Abrams; Nadia N Laack; Ralph Levitt; Evanthia Galanis; Jan C Buckner; Edward G Shaw
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

4.  Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.

Authors:  E Shaw; R Arusell; B Scheithauer; J O'Fallon; B O'Neill; R Dinapoli; D Nelson; J Earle; C Jones; T Cascino; D Nichols; R Ivnik; R Hellman; W Curran; R Abrams
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

6.  A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

Authors:  A B Karim; B Maat; R Hatlevoll; J Menten; E H Rutten; D G Thomas; F Mascarenhas; J C Horiot; L M Parvinen; M van Reijn; J J Jager; M G Fabrini; A M van Alphen; H P Hamers; L Gaspar; E Noordman; M Pierart; M van Glabbeke
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-10-01       Impact factor: 7.038

7.  A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.

Authors:  N M Bleehen; D J Girling; A Gregor; R C Leonard; D Machin; C G McKenzie; D A Morgan; J F Smyth; M F Spittle; R J Stephens
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

8.  Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Authors:  Brigitta G Baumert; Monika E Hegi; Martin J van den Bent; Andreas von Deimling; Thierry Gorlia; Khê Hoang-Xuan; Alba A Brandes; Guy Kantor; Martin J B Taphoorn; Mohamed Ben Hassel; Christian Hartmann; Gail Ryan; David Capper; Johan M Kros; Sebastian Kurscheid; Wolfgang Wick; Roelien Enting; Michele Reni; Brian Thiessen; Frederic Dhermain; Jacoline E Bromberg; Loic Feuvret; Jaap C Reijneveld; Olivier Chinot; Johanna M M Gijtenbeek; John P Rossiter; Nicolas Dif; Carmen Balana; Jose Bravo-Marques; Paul M Clement; Christine Marosi; Tzahala Tzuk-Shina; Robert A Nordal; Jeremy Rees; Denis Lacombe; Warren P Mason; Roger Stupp
Journal:  Lancet Oncol       Date:  2016-09-27       Impact factor: 54.433
  8 in total
  1 in total

Review 1.  Molecular Biology in Treatment Decision Processes-Neuro-Oncology Edition.

Authors:  Andra V Krauze; Kevin Camphausen
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.